Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010305 |
Xpovio (100 MG Once Weekly) Oral Tablet Therapy Pack 50 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010207 |
Xpovio (40 MG Once Weekly) Oral Tablet Therapy Pack 40 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010206 |
Xpovio (40 MG Twice Weekly) Oral Tablet Therapy Pack 40 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010401 |
Xpovio (60 MG Once Weekly) Oral Tablet Therapy Pack 60 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010103 |
Xpovio (60 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010202 |
Xpovio (80 MG Once Weekly) Oral Tablet Therapy Pack 40 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000127 |
Karyopharm Therapeutics Inc. |
04/23/2025 |
72237010104 |
Xpovio (80 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG |
01/01/2025 |
2117.00 |
32787.00 |
08/14/2035 |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000264 |
Kedrion Biopharma Inc. |
01/02/2025 |
76125090010 |
gammaked 10% carton w/ 1 x 100ml vial |
01/01/2025 |
46.61 |
1027.92 |
None |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Kedrions price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure |
Rx0000264 |
Kedrion Biopharma Inc. |
01/02/2025 |
76125090001 |
gammaked 10% carton w/ 1 x 10ml vial |
01/01/2025 |
9.32 |
205.58 |
None |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Kedrions price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure |
Rx0000264 |
Kedrion Biopharma Inc. |
01/02/2025 |
76125090020 |
gammaked 10% carton w/ 1 x 200ml vial |
01/01/2025 |
93.22 |
2055.83 |
None |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Kedrions price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure |
Rx0000264 |
Kedrion Biopharma Inc. |
01/02/2025 |
76125090050 |
gammaked 10% carton w/ 1 x 50ml vial |
01/01/2025 |
186.45 |
4111.68 |
None |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Kedrions price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure |
Rx0000386 |
KVK Tech, Inc. |
04/14/2025 |
10702000125 |
Lomaira Oral Tablet 8 MG 250ct |
02/06/2025 |
29.12 |
149.95 |
None |
Non-innovator Multiple Source Drug |
None |
None |
650 |
None |
Inflation based on the Consumer Price Index (CPI) |
None |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Drug was not acquired within the last 5 years |
Rx0000386 |
KVK Tech, Inc. |
04/14/2025 |
10702000109 |
Lomaira Oral Tablet 8 MG 90ct |
01/01/2025 |
4.83 |
57.97 |
None |
Non-innovator Multiple Source Drug |
None |
None |
142000 |
None |
Inflation based on the Consumer Price Index (CPI) |
None |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Drug was not acquired within the last 5 years |
Rx0000386 |
KVK Tech, Inc. |
02/19/2025 |
10702007106 |
Oxymorphone 10mg 60ct |
02/17/2025 |
226.86 |
248.00 |
None |
Non-innovator Multiple Source Drug |
None |
None |
779424 |
None |
The cost of raw material increases. The cost of DEA compliance/SOMS has also increased exponentially with the nationwide opioid litigation |
None |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Drug was not acquired within the last 5 years |
Rx0000386 |
KVK Tech, Inc. |
02/19/2025 |
10702007006 |
Oxymorphone 5mg 60ct |
02/17/2025 |
80.27 |
101.00 |
None |
Non-innovator Multiple Source Drug |
None |
None |
1 |
None |
The cost of raw material increases. The cost of DEA compliance/SOMS has also increased exponentially with the nationwide opioid litigation |
None |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Drug was not acquired within the last 5 years
Also- we had $0 in sales for that NDC, and it was giving me an error, so I just plugged in $1 |